Skip to content

Sing for Your Saunter - Dementia Supplement

Sing for Your Saunter: Using Self-generated Rhythmic Cues to Enhance Gait in Parkinson's - Dementia Supplement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04518917
Acronym
SFYS-D
Enrollment
17
Registered
2020-08-19
Start date
2021-04-19
Completion date
2023-05-15
Last updated
2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease, Parkinson Disease Dementia

Keywords

Parkinson disease, Music, Mental singing, Gait

Brief summary

Older adults, and particularly those with Parkinson disease (PD), may experience walking difficulties that negatively impact their daily function and quality of life. People that have PD plus dementia are also likely to experience walking difficulties. This project will examine the impact of music and mentally singing on walking performance, with a goal of understanding what types of rhythmic cues are most helpful. Pilot work from the investigators suggests that imagined, mental singing (i.e., singing in head) while while walking helps people walk faster with greater stability, whereas walking to music also helps people walk faster but with reduced stability. In this study, the investigators will recruit people who have PD plus dementia. The investigators will compare walking while mentally singing and walking while listening to music, using personalized cues tailored to each person's walking performance. The investigators hypothesize temporal variability of gait will be lower in the mental singing and singing conditions compared to listening to music; and that mental singing, singing, and listening to music will elicit similar improvements in stride length.

Detailed description

During this observational study, participants will attend one visit in the laboratory. The visit will include participants wearing wearable sensors during the following tasks: walking with no cues (UNCUED), walking while listening to music (MUSIC), and walking while mentally singing (MENTAL SINGING). The wearable sensors will measure gait parameters including gait speed, stride length, and stride time variability.

Interventions

Participants sing their song in their head and match their footfalls to the beat.

Participants listen to their song and match their footfalls to the beat.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 30 years of age * diagnosis of idiopathic, typical Parkinson disease according to the UK Brain Bank Criteria * Hoehn & Yahr stages 2-3 (mild to moderate disease severity) * normal or corrected hearing * stable on all PD medications for at least 2 months prior to study entry * dementia as defined by a Clinical Dementia Rating (CDR) score of 0.5-1.0 (very mild to mild dementia) * score of ≥ 1 on the MDS-UPDRS-III Item #10 indicating observable gait impairment * a score of 1 or less on item #7 on the freezing of gait questionnaire * able to walk for 10 continuous minutes independently

Exclusion criteria

* diagnosis of any other neurological condition * unstable medical or concomitant illnesses or psychiatric conditions which, in the opinion of the investigators, would preclude successful participation * cardiac problems that interfere with ability to safely participate (i.e., uncontrolled congestive heart failure, myocardial infarction in past 6 months, complex cardiac arrhythmias, significant left ventricular dysfunction, dyspnea on exertion, chest pain or pressure, resting tachycardia (\>100 beats/min); uncontrolled BP (resting systolic BP \>160 mmHg or diastolic BP \>100 mmHg)) * orthopedic problems in the lower extremities or spine that may limit walking (i.e., severe arthritis, spinal stenosis) * uncontrolled tremor or dyskinesia while on PD medications

Design outcomes

Primary

MeasureTime frameDescription
VelocityBaselineMeasured with wearable sensors by APDM Wearable Technology
Stride LengthBaselineMeasured with wearable sensors by APDM Wearable Technology

Countries

United States

Participant flow

Participants by arm

ArmCount
Parkinson Disease Plus Dementia
Participants will have a diagnosis of Parkinson disease plus dementia. Mentally Singing: Participants sing their song in their head and match their footfalls to the beat. Listening to music: Participants listen to their song and match their footfalls to the beat. Singing: Participants will sing their song out loud and match their footfalls to the beat.
17
Total17

Baseline characteristics

CharacteristicParkinson Disease Plus Dementia
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
17 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous72.7 years
STANDARD_DEVIATION 5.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
16 Participants
Region of Enrollment
United States
17 Participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 17
other
Total, other adverse events
0 / 17
serious
Total, serious adverse events
0 / 17

Outcome results

Primary

Stride Length

Measured with wearable sensors by APDM Wearable Technology

Time frame: Baseline

Population: For the uncued column the condition is by definition one with no cues. As such, there are no data for the 90, 100, 110, and 120% cue rows as these are only relevant for the cued conditions. Similarly, the mental singing and music conditions are by definition cued so there are no data for the no cue row as that is only relevant for the uncued condition.

ArmMeasureGroupValue (MEAN)Dispersion
Mental SingingStride Length90% cue tempo1.085 metersStandard Deviation 0.254
Mental SingingStride Length110% cue tempo1.130 metersStandard Deviation 0.274
Mental SingingStride Length100% cue tempo1.116 metersStandard Deviation 0.262
Mental SingingStride Length120% cue tempo1.128 metersStandard Deviation 0.265
MusicStride Length120% cue tempo1.129 metersStandard Deviation 0.272
MusicStride Length90% cue tempo1.089 metersStandard Deviation 0.26
MusicStride Length100% cue tempo1.103 metersStandard Deviation 0.258
MusicStride Length110% cue tempo1.130 metersStandard Deviation 0.266
UncuedStride LengthNo cue1.12 metersStandard Deviation 0.03
Primary

Velocity

Measured with wearable sensors by APDM Wearable Technology

Time frame: Baseline

Population: For the uncued column the condition is by definition one with no cues. As such, there are no data for the 90, 100, 110, and 120% cue rows as these are only relevant for the cued conditions. Similarly, the mental singing and music conditions are by definition cued so there are no data for the no cue row as that is only relevant for the uncued condition.

ArmMeasureGroupValue (MEAN)Dispersion
Mental SingingVelocity90% tempo cue.977 meters per secondStandard Deviation 0.234
Mental SingingVelocity100% tempo cue1.042 meters per secondStandard Deviation 0.27
Mental SingingVelocity110% tempo cue1.070 meters per secondStandard Deviation 0.286
Mental SingingVelocity120% tempo cue1.083 meters per secondStandard Deviation 0.29
MusicVelocity120% tempo cue1.072 meters per secondStandard Deviation 0.301
MusicVelocity110% tempo cue1.072 meters per secondStandard Deviation 0.279
MusicVelocity90% tempo cue.960 meters per secondStandard Deviation 0.243
MusicVelocity100% tempo cue1.011 meters per secondStandard Deviation 0.255
UncuedVelocityNo cue1.02 meters per secondStandard Deviation 0.04

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026